Arnold Fridland - Concepedia

Author

Arnold Fridland

St. Jude Children's Research Hospital

Also Known As

A Fridland, A. FRIDLAND, A. Fridland, ARNOLD FRIDLAND, Arnold FRIDLAND, Arnold Fridland, Fridland, A

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital Gilead Sciences (United States)University of Tennessee Health Science Center National Cancer Institute National Institutes of Health

About

Arnold Fridland is an author at St. Jude Children's Research Hospital specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	28	2.1K
2	Natural Sciences	14	14	877
3	Biochemistry	13	15	862
4	Engineering	2	2	51
5	Health Sciences	1	1	46

Arnold Fridland

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs John D. Schuetz, Michele Connelly, Daxi Sun, Nature Medicine Unidentified FactorMedicineAntiviral Drug DevelopmentAntiviral TherapyMolecular Biology	1999	577
Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- <i>R</i> -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA Brian L. Robbins, R V Srinivas, Choung Kim, Antimicrobial Agents and Chemotherapy	1998	319
Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells. Mark Johnson, Arnold Fridland Molecular Pharmacology	1989	178
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. David A. Cooney, Neil R. Hartman, Carlo Federico Perno, Molecular Pharmacology	1988	160
Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity Gurpreet S. Ahluwalia, David A. Cooney, Hiroaki Mitsuya, Biochemical Pharmacology Molecular PharmacologyHiv InfectivityMedicineAntiviral Drug DevelopmentAntiviral Therapy	1987	147
Human Immunodeficiency Virus Protease Inhibitors Serve as Substrates for Multidrug Transporter Proteins MDR1 and MRP1 but Retain Antiviral Efficacy in Cell Lines Expressing These Transporters R V Srinivas, David S. Middlemas, Pat Flynn, Antimicrobial Agents and Chemotherapy	1998	145
Role of Purine Nucleoside Phosphorylase in Interactions between 2′,3′-Dideoxyinosine and Allopurinol, Ganciclovir, or Tenofovir Adrian S. Ray, Loren Olson, Arnold Fridland Antimicrobial Agents and Chemotherapy Molecular PharmacologyPharmaceutical ScienceTranslational PharmacologyPnp-dependent DegradationCellular Enzymology	2004	125
Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells. Mark Johnson, Gurpreet S. Ahluwalia, Michele Connelly, Journal of Biological Chemistry Adenosine KinaseAdenosine Kinase ActivityImmunologyAntiviral DrugHuman Immunodeficiency Virus	1988	122
Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. David K. Kalwinsky, A. Thomas Look, Jonathan M. Ducore, PubMed Dna DamageDna BreakageDna AnalysisMolecular BiologyCell Cycle	1983	114
Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells Brian L. Robbins, Jack Greenhaw, Michele Connelly, Antimicrobial Agents and Chemotherapy Cell DeathChemical BiologyHuman Lymphoid CellsOxidative StressPmea-resistant Subline	1995	106

Page 1